-
Abstract Number: PB2099
JAK2 Mutation: A Predictor of Thrombotic Events in Myeloproliferative Neoplasia?
-
Abstract Number: PB0917
Joint Bleeding Outcomes in Patients with Hemophilia A Receiving Long-Term Prophylaxis with BAY 94-9027 in the PROTECT VIII Extension Study
-
Abstract Number: PB1015
Joint Damage in Non-severe Hemophilia A – Preliminary Results from an Explorative Study
-
Abstract Number: PB0900
Joint Health Outcomes in Patients with Hemophilia A Receiving Antihemophilic Factor (Recombinant) in a Real-World Setting: Results of a 6-Year Interim Analysis of the AHEAD International Study
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.